Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov;446(1-2):66-76.
doi: 10.1016/j.virol.2013.07.019. Epub 2013 Aug 15.

Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN

Affiliations

Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN

Kabamba B Alexandre et al. Virology. 2013 Nov.

Abstract

We examined the ability of HIV-1 subtype C to develop resistance to the inhibitory lectins, griffithsin (GRFT), cyanovirin-N (CV-N) and scytovirin (SVN), which bind multiple mannose-rich glycans on gp120. Four primary HIV-1 strains cultured under escalating concentrations of these lectins became increasingly resistant tolerating 2 to 12 times their 50% inhibitory concentrations. Sequence analysis of gp120 showed that most had deletions of 1 to 5 mannose-rich glycans. Glycosylation sites at positions 230, 234, 241, 289 located in the C2 region and 339, 392 and 448 in the C3-C4 region were affected. Furthermore, deletions and insertions of up to 5 amino acids in the V4 region were observed in 3 of the 4 isolates. These data suggest that loss of glycosylation sites on gp120 as well as rearrangement of glycans in V4 are mechanisms involved in HIV-1 subtype C escape from GRFT, CV-N and SVN.

Keywords: Cyanovirin-N; Entry inhibitor; Glycans; Griffithsin; HIV subtype C; Microbicide; Resistance; Scytovirin; Single genome amplification.

PubMed Disclaimer

Figures

Figure 1
Figure 1. In vitro generation of GRFT, CV-N and SVN resistant viruses
Primary HIV-1 subtype C isolates Du179 (A), Du151 (B), Du422 (C) and COT9 (D) were cultured in PBMC under escalating concentrations of GRFT, CV-N and SVN. The concentration of each lectin was gradually increased or reduced depending on the viral growth compared to the control cultures (containing no lectin) as determined by p24 antigen ELISA. The arrows indicate the time-point that the supernatant was collected for analysis.
Figure 2
Figure 2. Lectin-selected viruses showed a decreased sensitivity to GRFT, CV-N and SVN
Resistant primary HIV-1 subtype C isolates Du179 (A), Du151 (B), Du422 (C) and COT9 (D) were tested against GRFT, CV-N and SVN in a PBMC neutralization assay. The neutralization of HIV-1 infection was measured by p24 ELISA and the IC80 of the resistant virus and the corresponding wild-type were determined by linear regression. Bars represent standard deviation of three independent experiments.
Figure 3
Figure 3. Cross-resistance between GRFT, CV-N and SVN
Du179 virus selected by GRFT (A), CV-N (B) and SVN (C) were tested against all three lectins in a PBMC assay. HIV-1 neutralization was measured by p24 ELISA and the IC80 of the resistant virus (grey bar) and the corresponding wild-type (white bar) were determined by linear regression. Bars represent standard deviation of three independent experiments.
Figure 4
Figure 4. Mannose-rich glycosylation sites deleted in GRFT, CV-N and SVN selected viruses
The X-axis shows the positions of mannose-rich glycans deleted in the four isolates under lectin selective pressure. The positions of glycans are numbered according to the HxB2 virus (Leonard et al., 1990) and were identified by sequence analysis. The Y-axis shows the number of resistant viruses (out of 4) that had the deletion.
Figure 5
Figure 5. Changes in gp120 associated with lectin selection
Position of mannose-rich glycans and amino acid sequences for Du179 (A), Du151 (B), Du422 (C) and COT9 (D) following selection by GRFT, CV-N and SVN. Glycan deletions are shown in red and the addition in green. Symbols indicate changes in response to GRFT (*), CV-N (3) and SVN (3). Deletions and insertions of amino acid sequences in V4 are shown.
Figure 6
Figure 6. Amino acid sequence of isolated GRFT, CV-N and SVN resistant Du179 clones
GRFT (A), CV-N (B) and SVN (C) resistant Du179 clones gp120 sequence isolated by single genome amplification were aligned with their respective population sequences. The grey shading shows the presence of a potential mannose-rich glycosylation site, yellow shading indicates the site deletion while the red box shows the tip of the V3 loop (McCaffrey et al., 2004). Note that the glycan at position 393 is labeled as 392 in the text for comparison with other viruses.
Figure 6
Figure 6. Amino acid sequence of isolated GRFT, CV-N and SVN resistant Du179 clones
GRFT (A), CV-N (B) and SVN (C) resistant Du179 clones gp120 sequence isolated by single genome amplification were aligned with their respective population sequences. The grey shading shows the presence of a potential mannose-rich glycosylation site, yellow shading indicates the site deletion while the red box shows the tip of the V3 loop (McCaffrey et al., 2004). Note that the glycan at position 393 is labeled as 392 in the text for comparison with other viruses.

References

    1. Alexandre KB, Gray ES, Lambson BE, Moore PL, Choge IA, Mlisana K, Karim SS, McMahon J, O’Keefe B, Chikwamba R, Morris L. Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin. Virology. 2010;402:187–196. - PMC - PubMed
    1. Alexandre KB, Gray ES, Pantophlet R, Moore PL, McMahon JB, Chakauya E, O’Keefe BR, Chikwamba R, Morris L. Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site. J Virol. 2011;85:9039–9050. - PMC - PubMed
    1. Balzarini J. Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. Lancet Infect Dis. 2005;5:726–731. - PubMed
    1. Balzarini J, Van Laethem K, Hatse S, Froeyen M, Van Damme E, Bolmstedt A, Peumans W, De Clercq E, Schols D. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis. Mol Pharmacol. 2005;67:1556–1565. - PubMed
    1. Balzarini J, Van Laethem K, Hatse S, Vermeire K, De Clercq E, Peumans W, Van Damme E, Vandamme AM, Bolmstedt A, Schols D. Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins. J Virol. 2004;78:10617–10627. - PMC - PubMed

Publication types

MeSH terms